leonard schleifer. he is the founder and ceo of regeneron pharmaceuticals. guest: thank you for having me. host: you are working on covid-19 treatment and a possible vaccine for this. explain what your company is doing and the breakthroughs you would -- the breakthroughs you hope to achieve. guest: i think of it in three parts. first you have the office shelf solutions. is there anything here and now that we have, approved drugs that might be repurposed to try and attack this virus? a lot of them are being tried. i don't think all of them are going to work but it is worth trying. in that vein we have something that blocks the inflammation. it is a drug we have been working night and day and weekend. i have been in contact with people from the white house. me wantingve called to know what should be in the bill to help people be ready to deploy this cocktail. are in the epicenter right here in westchester county. it is terrible. i have a friend who was very sick for a long time. i have a friend right now who has been on a ventilator for several weeks. it is te

leonard schleifer "washington journal dr. leonard schleifer78 john auerbac >> [indiscernible] >> we have been watching that very closely and have not had false positives. >> do you have any in-person activities that might be required to receive the unemployment. >> we are still getting applications to come in and we will look at that and the applications coming in, but right now, we are not suspending the requirements. the adverse requirements, we are able to do that online or by phone. the hospitals are getting more funding than almost any other area that the state budget covers. how much are the hospitals getting? >> $100 billion nationally. >> the state has no options. the state has no money. if you are getting -- the federal bill had $100 million for hospitals. for coronavirus related expenses. they are doing better than anyone else. >> [inaudible] >> we will move all of the elections to june. >> [inaudible] >> we have not had that conversation. >> hospitals are required to have birthing partners in the room with individua

leonard schleifer, the founder and ceo of regeneron, based in new york.oom froming us via westchester, new york. we will get to your phone calls and we have a phone line set aside for medical professionals. that number is (202)-748-8002. maria in washington, d.c., good morning. caller: good morning. my question has to deal with those who consider this hysteria or that we are just making things up because it is a regular flu. correct me if i am wrong and maybe expand on it, it is about the rate, especially of mortality. 0.2% versus it is a a 0.01% for a regular flu out of 1000 people? one would die from a regular flu versus 20 from the coronavirus or something like that. that soake the point many more people will need andnded care like icu care that is why we worry so much. if you can clarify about that. host: thank you for the call. guest: great question. you probably have the figures right although frankly it is hard to know how to make these calculations because we don't know how many people have infections but it looks like this virus could be five to

leonard schleifer, ceo of regeneron pharmaceuticals discusses his company's work with the federal government to philip drug therapies to treat covid-19 patients. -- to develop. then trust for america's health ceo john auerbach will be with us to talk about the u.s. response to the virus pandemic. watch c-span's washington journal, live at 7:00 eastern sunday morning. join the discussion. ♪ the white house did not release a weekly address from the president. senator gary peters of michigan gave the democratic address discussing the federal response to t c

gilead and regeneron leonard schleifer will join us on "the exchange" to tell us more. >> schleifer told the president there is precedent or vaccines to make it worse you don't want to treat people and make 900,000 peopleworse >> absolutely he and his partner george instrumental in solving ebola and i know that the president apparently calls him lenny. len was my first guest on "mad money. the stock was 5 and went to 500. remarkable guy i don't know him well enough to call him lenny may be president's first time but that 1:00 interview will be important. this is a man who has been in the trenches and can tell the truth and is working very hard on doing exactly what we want, which is solve, solve. >> a lot of news headed our way the next couple hours. we'll monitor mnuchin and house ways and means on the tape this morning making comments about the g7, we'll get you that after the break. check out our podcast, listen to the opening bell hours "squawk on the street" wherever you hear podcasts, we're back in just a moment. a golf course is designed to be difficult. to challenge your thinking

leonard schleifer. >> great to have you thanks very much for joining us onnon thanks for having me.t to hear wonderful news that you are bringing i think the world needs to hear this, tell us, about the breakthrough, on your coronavirus drug, and where you stand with that today. on the phone: . >> as you might imagine no matter what crisis is you need a strategy to deal with it, the innovate industry biopharmaceutical industry taking three approaches first what do we have on the shelf, ready to deploy that might make a difference. and in that vein people are trying antivirals we hope might work trying a drug we hope might block the havoc this virus workweeks on lounges it causes tremendous damage we are hoping this inflammatory damage to lungs mys be blocked by this drug, we had encouraging news about that, out of china, from a similar drug made by roach so we are looking, in fact we started testing, in the united states, on that. so we will see how that goes. beyond what is already on the shelf, one has to come up with something rapidly that might be able to attack this virus the n

leonard schleifer. he is the founder and ceo of regeneron pharmaceuticals. guest: thank you for having me. host: you are working on covid-19 treatment and a possible vaccine for this. explain what your company is doing and the breakthroughs you would -- the breakthroughs you hope to achieve. guest: i think of it in three parts. first you have the office shelf solutions.

leonard schleifer, ceo of regeneron pharmaceuticals discusses his company's work with the federal government to philip drug therapies to treat covid-19 patients. -- to develop. then trust for america's health ceo john auerbach will be with us to talk about the u.s. response to the virus pandemic. watch c-span's washington journal, live at 7:00 eastern sunday morning. join the discussion. ♪ the white house did not release a weekly address from the president. senator gary peters of michigan gave the democratic address discussing the federal response to the coronavirus pandemic. i am gary peters, probably representing michigan in the united states senate. typically you would see the democratic weekly address from a studio. but, like americans across the country, i am faxing social distancing, and join you from my home in michigan. -- i am practicing social distancing. we are facing an unprecedented public health emergency, and an economic crisis of epic proportions. as cases of coronavirus skyrocket, i and my senate democratic colleagues work to protect the health and safety of people across th